JUDY JUSTUS: Open Payments
NPI 1710431853 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 29 payments from 4 companies in 2025. Trend: 2023 $662 · 2024 $921 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $492 |
| Gilead Sciences, Inc. | 14 | $330 |
| Novo Nordisk Inc | 2 | $61 |
| Mirum Pharmaceuticals, Inc. | 1 | $24 |
Products named: MAVYRET, Wegovy, Livmarli.
Industry payments across CA — which companies pay providers there.
